Koh Izumiyama

848 total citations
55 papers, 609 citations indexed

About

Koh Izumiyama is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Koh Izumiyama has authored 55 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 16 papers in Pathology and Forensic Medicine and 15 papers in Oncology. Recurrent topics in Koh Izumiyama's work include Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Koh Izumiyama is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Koh Izumiyama collaborates with scholars based in Japan and United States. Koh Izumiyama's co-authors include Akio Mori, Masahiro Asaka, Takeshi Kondo, Satoshi Hashino, Masahiro Onozawa, Kaoru Kahata, Shuichi Ota, Masakatsu Yonezumi, Makoto Saito and Junji Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Koh Izumiyama

48 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koh Izumiyama Japan 13 207 147 139 130 124 55 609
Mónica Jiménez Spain 9 135 0.7× 204 1.4× 93 0.7× 130 1.0× 160 1.3× 12 521
Önder Arslan Türkiye 16 201 1.0× 47 0.3× 132 0.9× 354 2.7× 159 1.3× 81 779
Federico Silvestri Italy 13 133 0.6× 208 1.4× 230 1.7× 138 1.1× 169 1.4× 30 632
Kenji Fukuno Japan 13 110 0.5× 211 1.4× 65 0.5× 262 2.0× 229 1.8× 31 667
A. Della Volpe Italy 13 164 0.8× 55 0.4× 49 0.4× 110 0.8× 156 1.3× 27 629
Hülya Çetınkaya Türkiye 17 472 2.3× 211 1.4× 330 2.4× 41 0.3× 139 1.1× 48 989
Entezam Sahovic United States 12 155 0.7× 51 0.3× 74 0.5× 339 2.6× 165 1.3× 30 613
Nadia Cecconi Italy 12 111 0.5× 128 0.9× 125 0.9× 62 0.5× 90 0.7× 33 402
Patricia M. Miron United States 13 446 2.2× 111 0.8× 502 3.6× 227 1.7× 92 0.7× 36 1.1k
D. Canioni France 12 92 0.4× 237 1.6× 73 0.5× 68 0.5× 191 1.5× 24 636

Countries citing papers authored by Koh Izumiyama

Since Specialization
Citations

This map shows the geographic impact of Koh Izumiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh Izumiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh Izumiyama more than expected).

Fields of papers citing papers by Koh Izumiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koh Izumiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh Izumiyama. The network helps show where Koh Izumiyama may publish in the future.

Co-authorship network of co-authors of Koh Izumiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Koh Izumiyama. A scholar is included among the top collaborators of Koh Izumiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh Izumiyama. Koh Izumiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mori, Akio, Masahiro Onozawa, Hajime Senjo, et al.. (2023). Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies. Cancer Medicine. 12(16). 16881–16888. 2 indexed citations
3.
Mori, Akio, Masahiro Onozawa, Hajime Senjo, et al.. (2023). Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms. Annals of Hematology. 102(4). 819–827. 2 indexed citations
4.
Chiba, Masahiro, Joji Shimono, Takashi Ishio, et al.. (2022). Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas. Blood. 140(18). 1951–1963. 21 indexed citations
5.
Mori, Akio, Masahiro Onozawa, Hajime Senjo, et al.. (2022). Humoral response to mRNA‐based COVID‐19 vaccine in patients with immune thrombocytopenia. British Journal of Haematology. 200(6). 717–721.
6.
Saito, Makoto, Akio Mori, Takashi Ishio, et al.. (2022). Duodenal-type follicular lymphoma more than 10 years after treatment intervention: A retrospective single-center analysis. World Journal of Gastrointestinal Oncology. 14(8). 1552–1561. 6 indexed citations
7.
Saito, Makoto, et al.. (2021). Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia. Cureus. 13(8). e17478–e17478. 3 indexed citations
8.
Saito, Makoto, Masanobu Morioka, Koh Izumiyama, et al.. (2021). Phlegmonous gastritis developed during chemotherapy for acute lymphocytic leukemia: A case report. World Journal of Clinical Cases. 9(22). 6493–6500. 2 indexed citations
9.
Senjo, Hajime, Kenji Hirata, Koh Izumiyama, et al.. (2020). High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma. Blood Advances. 4(10). 2286–2296. 37 indexed citations
10.
11.
Saito, Makoto, Hajime Senjo, Minoru Kanaya, et al.. (2018). Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents. Hematology Reports. 10(2). 7453–7453.
12.
Izumiyama, Koh, et al.. (2017). REVIEW OF THE RECENT NORTHEN SEA ROUTE ACTIVITIES. Journal of Japan Society of Civil Engineers Ser B3 (Ocean Engineering). 73(2). I_25–I_30. 2 indexed citations
13.
Saito, Makoto, Minoru Kanaya, Koh Izumiyama, et al.. (2016). Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases. International Journal of General Medicine. Volume 9. 393–399. 2 indexed citations
14.
Saito, Makoto, Koh Izumiyama, Akio Mori, et al.. (2014). [Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].. PubMed. 55(1). 130–2. 4 indexed citations
15.
Saito, Makoto, Koh Izumiyama, Akio Mori, et al.. (2013). Biphenotypic Acute Leukemia with t(15;17) Lacking Promyelocytic-Retinoid Acid Receptor α Rearrangement. SHILAP Revista de lepidopterología. 5(4). e16–e16. 4 indexed citations
16.
Hashino, Satoshi, Sumiko Kobayashi, Mutsumi Takahata, et al.. (2008). Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer. International Journal of Clinical Oncology. 13(2). 176–180. 4 indexed citations
17.
Onozawa, Masahiro, Satoshi Hashino, Koh Izumiyama, et al.. (2004). Aleukemic Leukemia Cutis in a Patient with Philadelphia Chromosome-Positive Biphenotypic Leukemia. International Journal of Hematology. 80(3). 278–280. 5 indexed citations
18.
Izumiyama, Koh, Masao Nakagawa, Masakatsu Yonezumi, et al.. (2003). Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma. Oncogene. 22(50). 8085–8092. 28 indexed citations
19.
Chiba, Kazuhiro, et al.. (2002). del11(p11-13) with overexpression of Wilms' tumor gene during leukemic transformation of myelodysplastic syndrome. Annals of Hematology. 81(10). 605–608. 2 indexed citations
20.
Takahata, Mutsumi, et al.. (2002). Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine. Bone Marrow Transplantation. 29(3). 269–271. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica Jiménez Breakdown of academic impact, for papers by Önder Arslan Breakdown of academic impact, for papers by Federico Silvestri Breakdown of academic impact, for papers by Kenji Fukuno Breakdown of academic impact, for papers by A. Della Volpe Breakdown of academic impact, for papers by Hülya Çetınkaya Breakdown of academic impact, for papers by Entezam Sahovic Breakdown of academic impact, for papers by Nadia Cecconi Breakdown of academic impact, for papers by Patricia M. Miron Breakdown of academic impact, for papers by D. Canioni
Rankless by CCL
2026